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Plasmodium falciparum blood-stage antigens in
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Abstract
Background: HBB, IL4, IL12, TNF, LTA, NCR3 and FCGR2A polymorphisms have been associated with malaria
resistance in humans, whereas cytophilic immunoglobulin G (IgG) antibodies are thought to play a critical role in
immune protection against asexual blood stages of the parasite. Furthermore, HBB, IL4, TNF, and FCGR2A have been
associated with both malaria resistance and IgG levels. This suggests that some malaria resistance genes influence
the levels of IgG subclass antibodies.
Methods: In this study, the effect of HBB, IL4, IL12, TNF, LTA, NCR3 and FCGR2A polymorphisms on the levels of IgG
responses against Plasmodium falciparum blood-stage extract was investigated in 220 individuals living in Burkina
Faso. The Pearson’s correlation coefficient among IgG subclasses was determined. A family-based approach was
used to assess the association of polymorphisms with anti-P. falciparum IgG, IgG1, IgG2, IgG3 and IgG4 levels.
Results: After applying a multiple test correction, several polymorphisms were associated with IgG subclass or IgG
levels. There was an association of i) haemoglobin C with IgG levels; ii) the FcγRIIa H/R131 with IgG2 and IgG3
levels; iii) TNF-863 with IgG3 levels; iv) TNF-857 with IgG levels; and, v) TNF1304 with IgG3, IgG4, and IgG levels.
Conclusion: Taken together, the results support the hypothesis that some polymorphisms affect malaria resistance
through their effect on the acquired immune response, and pave the way towards further comprehension of
genetic control of an individual’s humoral response against malaria.
Keywords: HBB, Immune genes, Plasmodium falciparum, Malaria, IgG subclass, Family-based association
Background
Plasmodium falciparum malaria is a major cause of
worldwide mortality and morbidity. Host genetic factors
have been shown to influence malaria infection intensity
and clinical malaria. Several candidate genes have been
associated with resistance against severe malaria, whereas
linkage or association analyses mapped several loci con-
trolling mild malaria and/or parasitemia [1]. Noticeably,
chromosomes 5q31-q33 and 6p21-p23 have been linked
to parasitaemia or mild malaria [2,3], whereas genes
located within those chromosomal regions have been
associated with parasitaemia, mild or severe malaria
[4-10]. The HBB locus has been shown to be a major
locus based on a genome association study for severe
malaria, whereas haemoglobin S (HbS) and haemoglo-
bin C (HbC) have been associated with protection
against mild and severe malaria in a large number of
studies. It should be stressed that a limited number of
genes have been associated with mild or severe malaria
in several independent studies; these include FCGR2A
that encodes the human IgG receptor FcγRIIa.
Anti-P. falciparum IgG antibodies are thought to play
a critical role in immune protection against asexual
blood stages of the parasite. Passive transfer of IgG has
provided protection against the P. falciparum blood
stages in humans. In vitro, human IgGs that recognize
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either infected erythrocytes or merozoites act in cooper-
ation with monocytes to eliminate the parasite [11].
Cytophilic IgGs that activate effector cells are, therefore,
considered protective, while non-cytophilic IgGs against
the same epitope may block the protective effect of the
cytophilic ones. This hypothesis has been supported by
several immune-epidemiological studies. High levels of
the cytophilic IgG3 subclass have been associated with
reduced parasitaemia, and protection against mild and
severe malaria [12,13]. Interestingly, high levels of IgG2
could be correlated with protection in individuals carry-
ing the H131 variant of monocytes FcγRIIa receptor,
which efficiently binds to IgG2. In contrast, high levels
of non-cytophilic IgG4 antibodies have been associated
with susceptibility to malaria [14]. In this context, sev-
eral investigators have provided evidence of the genetic
control of IgG levels. Twin studies have shown a better
concordance in monozygotic twins than in dizygotic
twins for IgG levels [15]. In addition, high sib-sib correla-
tions for IgG subclass levels have been detected [16-18].
Further evidence of a genetic component has been pro-
vided by a survey conducted in several sympatric ethnic
groups having different genetic backgrounds [19]. Some
candidate genes have been associated with IgG or IgG
subclass levels. These include HBB, IL4, TNF, and
FCGR2A, which have also been associated with both mal-
aria resistance and IgG levels [1,20-25]. This suggests that
those genes control the production of cytophilic IgG sub-
classes. More generally, genes that have been associated
with malaria resistance may be associated with the level of
protective IgG subclasses. The linkage or association of
HBB, IL4, IL12,TNF, LTA, and NCR3 with mild malaria or
parasitaemia has been previously reported in a population
living in Burkina Faso [2,3,6,9,10,26]. The objective of this
study was to determine the influence of HBB, IL4, IL12,
TNF, LTA, NCR3 and FCGR2A polymorphisms on the
IgG subclass patterns of antibodies against P. falciparum
antigens in the same population by using a family-based
approach.
Methods
Subjects, clinical diagnosis, and parasitological data
The study population consisted of 220 individuals belong-
ing to 34 families living in urban district of Bobo Diou-
lasso in Burkina Faso, in which infected mosquitoes were
detected only during August, September and October; the
numbers of infective bites per person and per year was
30. Blood samples were taken from individuals in July
at the end of the dry season (P1) and in December at
the end of rainy season (P2). The mean age of sibs was
12.1+ 6.2 years (range one to 34 years). The study
population and the area of parasite exposure have been
described elsewhere [14,27]. Phenotypes and DNA were
available for all the individuals. The Medical Authority
of Burkina Faso approved the study protocol. Informed
consent for multiple immunoparasitological and clinical
surveys was obtained individually from all participants.
Febrile episodes were extensively recorded by active
case detection during 24 months. For patients with
fever, a thick blood film was prepared by the standard
procedures. Diagnosis of mild malaria attack was based
on P. falciparum parasitaemia, fever (axillary temperature
more than 37.5°C) and clinical symptoms (headache, ach-
ing, vomiting or diarrhoea in the children); in that case no
threshold of parasitaemia was used. In the absence of clas-
sical symptoms of malaria, and once others pathologies
could not be eliminated, only children (age < 15 years)
with more than 5,000 parasites per ml and older subjects
with more than 2,000 parasites per ml were considered as
having had a malaria attack. Each episode of illness was
treated according to the recommendation of the CNRFP
(Centre National de Recherche et Formation sur le Palu-
disme) of Burkina Faso. Parasitaemia was checked at the
end of the treatment. Subjects who presented at least one
mild malaria attack during the survey were considered in
the analysis affected, while the others were considered
unaffected.
Determination of parasitaemia was described in a pre-
vious study [26]. Briefly, each family was visited 20 times
during the 24 months of the study, and parasitaemia was
measured. In addition, parasitaemia was measured dur-
ing febrile episodes. The mean number of parasitaemia
measurements per subject was 15.2 + 5.1 (range 1–24).
Fingerprint peripheral blood samples were taken from
all family members present and thick and thin blood
films were stained with Giemsa. The parasite determin-
ation and numeration were established blindly from two
independent readings. Only P. falciparum asexual forms
were retained to determine parasitaemia. Parasitaemia
was defined as the number of parasitized erythrocytes
observed per μl in thin blood films.
Maximum parasitaemia was based on a logarithmic
transformation of the highest parasitaemia that was
measured in each individual during the survey [26].
Mean of adjusted asymptomatic parasitaemia was a loga-
rithmic transformation of the parasitaemia adjusted for
seasonal transmission [26], after excluding parasitaemia
during febrile episodes. To take into account the season-
ality of the transmission, the influence of the date of the
visits on ln(1 + parasitaemia) (LP) was evaluated by one
way analysis of variance. The mean LP observed during
each visit was calculated. The individual LP was then
corrected for the visit effect by subtracting from each in-
dividual LP the mean LP of the corresponding visit.
Since age influenced mild malaria attack, maximum
parasitaemia, and the mean of adjusted parasitaemia, the
age effect was further taken into account. Linear regres-
sion was carried out to calculate the residual for
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maximum parasitaemia and the mean of adjusted para-
sitaemia, whereas logistic regression was used to calcu-
late the residual for mild malaria. The residuals were
used as phenotypes for linkage and association analyses.
IgG sub-class phenotype determination
The measurements of IgG subclasses directed against
P. falciparum blood-stage extracts were previously per-
formed; the data sets previously reported was used
[14]. Briefly, the P. falciparum W2 strain (Southeast
Asia) was maintained and synchronized. Schizonts
were isolated from infected red blood cells based on a
treatment with saponin, were sonicated on ice in
phosphate-buffered saline containing protease inhibi-
tors. Sonicates were centrifuged, and the supernatants
were filtered through a 0.22 μm-pore-size membrane,
and were aliquoted and stored at −70°C until use.
Enzyme-linked immunosorbent assay (ELISA) plates
(Nunc) were coated with 1 μg of P. falciparum ex-
tract/ml in sodium carbonate buffer (100 mM, pH
9.6). Plates were saturated with 3% bovine serum albu-
min in phosphate-buffered saline. Serum dilutions were
incubated for 16 h at 4°C (1:20 for IgG2 and IgG4,
1:100 for IgG1 and IgG3, and 1:400 for IgG). The fol-
lowing monoclonal antibodies were used: anti-IgG1
(clone 8c/6-39; The Binding Site), IgG2 and IgG3
(clone HP 6002 and HP 6050; Clinisciences), and IgG4
(clone RJ4; Immunotech). Total IgG was detected
using a goat F(ab0)2 anti-human IgG (Jackson Labora-
tories). The anti-IgG1 and -IgG were conjugated to al-
kaline phosphatase, the anti-IgG2 and -IgG3 were
biotinylated, and the anti-IgG4 was unlabelled. F(ab0)2
anti-mouse IgG conjugated to alkaline phosphatase
was used for IgG4 detection. Signal amplification was
performed for IgG2 and IgG3 detection by using strep-
tavidin and biotinylated alkaline phosphatase (Pierce);
the sensitivity of the assay was 30-fold higher than that of
the assay using the same monoclonal antibodies conju-
gated to alkaline phosphatase. After 2 h of incubation at
room temperature, enzymatic activities were revealed by
p-nitrophenyl phosphate (Sigma) (1 mg/ml) in Tris buffer
(pH 9.6). The optical densities were read at 405 nm using
a DIAS automatic plate reader (Dynex Technology). A
pool of 200 sera equally diluted was used to draw a stand-
ard curve; the same serum pool was used for IgG, IgG1,
IgG2, IgG3 and IgG4 measurements. Fifty samples that
were randomly selected were titrated; the titration curves
were parallel to the standard curve for each IgG subclass.
All tests were done in duplicate, and antibody levels were
calculated by using the standard curve and were expressed
as arbitrary units (AU). To allow for zero values in further
analyses, a logarithmic transformation was applied based
on log (1+AU) (LAU) to the AU. The mean LAU and
standard deviation were calculated at P1 and at P2. To
correct the individual LAU for the visit effect, the LAU
was standardized at P1 and at P2, and the mean of
adjusted LAU (MALAU) was calculated for each subject,
as previously described. The influence of age and sex on
MALAU was further evaluated using polynomial regres-
sion; the age was considered as a continuous variable.
There was an effect of age on IgG subclass and IgG
levels (P < 0.01), whereas there was no influence of sex.
Age was retained for adjustment for each IgG subclass.
The residual was the phenotype used in the statistical
analyses. IgG, IgG1, IgG2, IgG3 and IgG4 phenotypes
were calculated for 193 individuals.
Genotyping
Blood samples were taken by venipuncture. The haemo-
globin genotypes were identified by electrophoresis of
red blood cell lysates on acetate membrane at an alkaline
pH. Acetate sheets were stained with Ponceau red. This
yielded discrimination of haemoglobin A (HbA), S (HbS)
and C (HbC).
DNA was extracted from mononuclear cells separated
by the Ficoll–Hypaque density gradient as described [27].
Samples were first subject to prior whole-genome amplifi-
cation by primer extension pre-amplification [28]. For IL4,
FCGR2A, NCR3, TNF, LTA, and IL12B polymorphisms,
the data sets previously reported were used [6,9,10,29,30].
Briefly, genotypes for NCR3, TNF, LTA, and IL12B poly-
morphisms have been obtained by sequencing with a CEQ
8000 automated fluorescent sequencer (Beckman Coulter,
Roissy CDG, France), whereas FCGR2A H/R131 geno-
types was determined by using PCR and allele-specific re-
striction enzyme digestion methods as previously
described [31]. The call rate was higher than 88% for all
the polymorphisms, based on the 193 individuals, for
which the IgG subclass levels have been measured; the
median call rate was 94%.
Statistical analyses
The correlation among IgG subclasses was evaluated
using Pearson's correlation coefficient. In addition, com-
bined association and linkage analyses were carried out
using the family-based association test (FBAT)
approaches [32]. The FBAT statistics, which use data
from sibships in nuclear families, takes into account sib-
ling correlations. The default null hypothesis is no link-
age or no association and the statistics under this
hypothesis calculates the distribution of offspring geno-
types that are conditional on parental genotypes and on
trait values. FBAT calculates a Z score and a two-side P-
value based on normal distribution. Multiple test correc-
tions was further performed using the false discovery
rate (FDR) method for all the statistical tests [33]; an
FDR of 10% was carried out.
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Results
Table 1 presents the summary of the correlation between
IgG sub-class levels. There were significant positive corre-
lations between all measured IgG subclasses (P< 0.0001).
In particular, IgG1 and IgG3 levels were highly correlated
(r = 0.631). The best correlations were between IgG levels
and IgG1 levels on the one hand and IgG levels and IgG3
levels on the other hand (r >0.7).
Allele frequencies for all single-nucleotide polymorph-
isms (SNPs) and previously reported family-based associa-
tions with parasitaemia and mild malaria are shown in
Table 2 and Additional file 1, respectively. Additional file
1 also shows the family-based associations of SNPs with
parasitaemia and mild malaria in individuals (n= 193), for
which the level of IgG subclasses has been measured.
HbC, LTA+80, TNF-1031, TNF-238, TNF1304, and
NCR3-412 were associated with parasitaemia or mild mal-
aria in this sub-population (Additional file 1). Moreover,
FcγRIIa H/R131 was associated with mild malaria in indi-
viduals, for which the level of IgG2 was higher than the
median (Additional file 1).
The family-based association of SNPs with the level of
IgG subclasses (IgG1, IgG2, IgG3, and IgG4) and IgG
against P. falciparum crude extract was further assessed.
The additive, the dominant, and the recessive models
were used for each SNP. The FBAT analysis gave a num-
ber of significant results at the nominal level of 0.05, al-
though there was no association of HbS, IL12Bpro, and
IL12B 3’ UTR, IL4-590, NCR3-412, NCR3-3790, TNF-
238, TNF-308, and TNF-1031 polymorphisms with the
IgG responses (Tables 2 and 3). After correcting for mul-
tiple tests, there were only some SNPs that were signifi-
cantly associated with anti-malarial IgG subclass levels,
as shown in Tables 2 and 3. The most significant finding
was a positive association between IgG2 levels and
FcγRIIa H131 based on a recessive model. Conversely,
IgG3 levels were negatively associated with FcγRIIa
H131 based on a dominant model. HbC was positively
associated with IgG levels based on an additive model.
Three TNF polymorphisms were associated with IgG
responses based on an additive model: TNF-863 and
TNF-857 were associated with IgG3 levels and IgG
levels, respectively, whereas TNF1304 was associated
with IgG3, IgG4, and IgG levels.
Discussion
The aim of this study was to determine the effect of sev-
eral candidate gene polymorphisms on the IgG subclass
responses against P. falciparum extract in a population
living in an endemic area in Burkina Faso. Most of the
candidates have been associated with parasitaemia, mild
or severe malaria [1].
There was positive correlation between all measured
antibody levels. Anti-malarial IgG levels were correlated
with all anti-malarial IgG subclasses. The best correla-
tions were the correlations of anti-malarial IgG levels
with anti-malarial IgG1 and IgG3 levels. A correlation
between all anti-P. falciparum IgG subclass levels was
observed, the best correlation being between IgG1 and
IgG3 levels. The results are similar to a study in Thai-
land, where anti-malarial IgG3 levels were correlated to
IgG1 and IgG2 levels [34]. The results are also coherent
with a recent study conducted in Sudan, where anti-
malarial IgG levels were correlated with each anti-
malarial IgG subclass against malarial antigen, and
Table 1 Correlation between anti-malarial IgG subclass
levels in individuals living in an endemic area in Burkina
Faso
IgG1 IgG2 IgG3 IgG4
IgG1 1
IgG2 0.373 a 1
IgG3 0.631 a 0.558 a 1
IgG4 0.467 a 0.326 a 0.46 a 1
IgG 0.71 a 0.537 a 0.787 a 0.507 a
aPearson's correlation coefficient with P< 0.0001.
Table 2 Family-based association analyses for
anti-Plasmodium falciparum IgG levels
Locus SNP ID
number
Allelea
(AFb)
Pc
IL12Bpro (promoter) rs17860508 TTAGAG/GC
(0.3068)
P > 0.05
IL12B (3'UTR) rs3212227 A/C (0.3275) P > 0.05
IL4-590 (promoter) rs2243250 C/T (0.8017) P > 0.05
FCGR2A H/R131 (exon 4) rs1801274 C/T (0.5371) Td (0.0166f)
HbC (exon1) rs33930165 A/C (0.1682) Cd (0.0091e,g)
HbS (exon1) rs334 A/T (0.0193) P > 0.05
LTA+ 80 (intron 1) rs2239704 C/A (0.3542) P > 0.05
TNF-1031(promoter) rs1799964 T/C (0.1106) P > 0.05
TNF-863 (promoter) rs1800630 C/A (0.0858) Ad (0.0440e)
TNF-857 (promoter) rs1799724 C/T (0.0228) Td (0.0064e,g)
TNF-308 (promoter) rs1800629 G/A (0.1063) P > 0.05
TNF-238 (promoter) rs361525 G/A (0.0264) P > 0.05
TNF1304 (intron 3) rs3093664 A/G (0.075) Ad (0.0083e,g)
NCR3-412 (promoter) rs27362191 G/C (0.2267) P > 0.05
NCR3*3790 (3'UTR) rs986475 T/C (0.0272) Cd (0.0307e)
Abbreviations: HbC, Haemoglobin C; IL4, Interleukin 4; LTA, Lymphotoxin-α; AF,
allele frequency; NCR3, Natural cytotoxicity receptor 3; SNP, Single-nucleotide
polymorphism; TNF, Tumour necrosis factor; UTR, Untranslated region.
aWild allele / variant allele.
bVariant allele frequency that was calculated in the study population.
cChi-square test P-value for IgG levels.
dAllele positively associated.
eAdditive model.
fDominant model.
gSignificant P value after applying a false discovery rate of 10%.
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where there was an age-dependent association of pro-
tective IgG2 and IgG3 subclasses [12,35]. Cytokines that
are effective in most of IgG subclass production could
partly explain the correlations between the IgG subclass
levels. IL4 induces switching to E, γ1, γ3, γ4 and also
enhances the expression of E, γ1, γ3 and γ4 germline
transcript, and the secretion of corresponding proteins
[36]. IL4-590 polymorphism does not explain, neverthe-
less, variation in the level of IgG subclasses, suggesting
that other IL4 polymorphisms should be investigated. In
addition, other cytokines, such as IL2, IL6, or IL10 are
also known to enhance the IgG production in vitro by B
cells activated by polyclonal activators or plasmodial anti-
gens [37,38]. Besides, IL10, which causes the switch to-
wards IgG1 and IgG3, likely explains the high correlation
between IgG1 and IgG3 levels [39]. Interestingly, IgG2
and IgG3 levels were also strongly correlated, whereas the
correlation between IgG1 and IgG2 levels was low. IFN-
gamma seems to inhibit IgG1 production in vitro, and to
enhance IgG2 production [40]. Although IFN-gamma is
unlikely an IgG2 switch factor, T cells producing IFN-
gamma, namely the Th1 (T helper 1) lymphocytes, have
been shown to produce an IgG2 switch factor acting on
CD40-activated naïve B cells [41]. These observations sug-
gest that cytokines produced by Th1 lymphocytes may
collectively increase the production of IgG2. In all, the
correlations between IgG subclass levels encourage to fur-
ther assess the production of cytokines in individual living
in endemic areas.
The family-based associations of candidate polymorph-
isms on the IgG subclass levels were further investigated.
There were some significant results after applying a mul-
tiple test correction. There was no association of IgG sub-
class levels with IL4 and IL12B polymorphisms, while
others reported an association of anti-malarial IgG levels
with IL4-590 [20]. There was no association between anti-
malarial IgG subclass levels and NCR3 polymorphisms, al-
though those may alter the production of IFN-gamma by
NK cells. The association of LTA+80 with all anti-
malarial IgG subclass levels was significant at the nominal
level of 5%, but was no more significant after applying a
multiple test correction; this polymorphism may, never-
theless, require further investigation to confirm or invali-
date the trend.
HbS and HbC have been associated with protection
against mild and severe malaria, and it has been proposed
that these polymorphisms could increase the elimination
of the parasite through acquired immune mechanisms
[42]. There was no association between HbS and anti-
malarial IgG responses, although other studies provided
evidence for a positive association [21,22]. These conflict-
ing results may be explained by the low frequency of HbS
Table 3 Family-based association analyses for anti-Plasmodium falciparum IgG subclass levels
IgG1 IgG2 IgG3 IgG4
Locus Pa Pa Pa Pa
IL12Bpro P > 0.05 P > 0.05 P > 0.05 P > 0.05
IL12B3’UTR P > 0.05 P > 0.05 P > 0.05 P > 0.05
IL4-590 P > 0.05 P > 0.05 Cb (0.0472d) P > 0.05
FCGR2A H/R131 P > 0.05 Tb (0.0003e,f) Cb (0.0010d,f) P > 0.05
HbC P > 0.05 Cb (0.0139d) P > 0.05 P > 0.05
HbS P > 0.05 P > 0.05 P > 0.05 P > 0.05
LTA + 80 Ab (0.0305c) Ab (0.0505c) Ab (0.0214c) Ab (0.0139c)
TNF-1031 P > 0.05 P > 0.05 P > 0.05 P > 0.05
TNF-863 Ab (0.0379c) P > 0.05 Ab (0.0082c,f) P > 0.05
TNF-857 P > 0.05 P > 0.05 Tb (0.0413c) Tb (0.0249c)
TNF-308 P > 0.05 P > 0.05 P > 0.05 P > 0.05
TNF-238 P > 0.05 P > 0.05 P > 0.05 P > 0.05
TNF1304 Ab (0.0495c) P > 0.05 Ab (0.0099c,f) Ab (0.0108c,f)
NCR3-412 P > 0.05 P > 0.05 P > 0.05 P > 0.05
NCR3*3790 P > 0.05 P > 0.05 Cb (0.0276c) Cb (0.0196c)
Abbreviations: HbC, Haemoglobin C; IgG, Immunoglobulin G; IL4, Interleukin 4; LTA, Lymphotoxin-α; NCR3, Natural cytotoxicity receptor 3; P. falciparum,
Plasmodium falciparum; TNF, Tumour necrosis factor.
aChi-square test P-value.
bAllele positively associated.
cAdditive model.
dDominant model.
eRecessive model.
fSignificant P value after applying a false discovery rate of 10%.
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in the study population. In contrast, HbC that was nega-
tively associated with maximum parasitemia and mild
malaria was positively associated with anti-malarial IgG
levels in the same population, further suggesting that HBB
polymorphisms alter the anti-malarial IgG production.
This result is consistent with previous reports also provid-
ing evidence for an involvement of HbC in the immune
response against infected erythrocytes through enhanced
IgG production [43,44]. This further supports the hypoth-
esis that the protection against malaria of HbC may be
partly mediated by acquired immunity against malaria,
more particularly by IgG-mediated effector mechanisms.
Interestingly, there was also a trend for the production of
anti-malarial IgG2 levels; although the association was not
significant after applying a multiple test correction, this
trend may require further attention in other populations.
The FcγRIIa H131 allele has been associated with pro-
tection from severe malaria in several populations [1].
Furthermore, it has been demonstrated to be the only
receptor for IgG2, the high level of which have been
associated with protection against P. falciparum malaria
in a population living in Burkina Faso [14], and in other
populations [45,46]. The FcγRIIa H131 allele has been
found to be particularly prevalent in the Fulani, who are
less affected by clinical malaria than individuals from
other ethnic groups; interestingly, the Fulani also
showed high levels of anti-malarial IgG2 [23,47]. On this
basis, an effect of the FcγRIIa H131 allele on anti-
malarial IgG2 levels was anticipated in this study. The
data provided evidence of a significant association of
FcγRIIa H131 allele with IgG2 levels based on a reces-
sive model. This family-based result is consistent with
population-based results previously published [22,23].
Together, these observations indicate that the FcγRIIa
H131 allele at the homozygous state increases the pro-
duction of anti-malarial IgG2. In the same way, there is
a trend for anti-malarial IgG levels based on a recessive
model, suggesting that the FcγRIIa H131 allele at the
homozygous state increases the production of anti-
malarial IgG, although the association was not signifi-
cant after correcting for multiple tests. Thus, the FcγRIIa
H131 allele may increase the phagocytosis by monocytes
or macrophages, and may favour the antigen presenta-
tion by these cells to the T helper lymphocytes; this hy-
pothesis remains to be assessed. Conversely, there was a
negative association of the FcγRIIa H131 allele with
anti-malarial IgG3 levels based on recessive model, sug-
gesting that the FcγRIIa H131 allele at the homozygous
state diminishes the level of anti-malarial IgG3. In the
same way, Israelsson et al. found that the FcγRIIa R131
allele carriers in the Fulani had higher anti-malarial
IgG3 levels than the individuals homozygous for the
FcγRIIa H131 allele. One might speculate that more
IgG3 will be present in the circulation of individuals
with the FcγRIIa R131 allele, because the FcγRIIa H131
allele has a higher binding than the FcγRIIa R131 allele
[48]. Nevertheless, the FcγRIIa H131 allele was asso-
ciated with higher levels of anti-malarial IgG3 in another
study in the Fulani [49]. It is likely that other factors
affecting the production of IgG subclass antibodies, such
as the cytokines or the antigens used, could partly ex-
plain the conflicting results [38].
In previous studies, TNF polymorphisms have been
related to severe malaria. SNPs at position −1031,-857,
-308,-238 and −863 in the promoter region of TNF
gene exhibit differential associations to malaria and
TNF production in different populations suggesting that
individual TNF responses may be genetically deter-
mined [7,8,50,51]. TNF1304 within intron 3 was asso-
ciated with variation in mild malaria and parasitaemia
[10], and TNF-308A and TNF-238A allele have been
associated with high anti-P. falciparum antibodies
[24,25]. In this study, there was no association of IgG
subclass levels with TNF-308 and TNF-238 polymorph-
isms. TNF-863A and TNF-857 T were, however, asso-
ciated with high anti-malarial IgG3 and IgG levels,
respectively. Moreover, there was an association of low
IgG3, IgG4, and IgG levels with TNF1304, which has
been associated with mild malaria and parasitaemia in
the same population [10]; this further supports the role
of TNF1304 on malaria phenotypes, although the effect
of the polymorphism on the molecular function or the
gene expression has not been reported. In contrast, the
molecular effect of polymorphisms within the TNF pro-
moter has been studied. Other authors reported that
the transcription factor OCT-1 binds specifically to the
TNF-863A and TNF-857 T alleles, that the transcrip-
tional promoter activity of a haplotype harbouring
TNF-863A and TNF-857 T was higher than the one of
other haplotypes in Japan [50,51]. An explanation for
association of TNF polymorphism with IgG response
could be that TNF gene is important in the develop-
ment of humoral response as an autocrine B-cell
growth factor [52].
Conclusions
Our results indicate that HbC, TNF-857T, and
TNF1304A were associated with high levels of anti-
malarial IgG. The FcγRIIa H131 allele was associated
with high levels of anti-malarial IgG2 and low levels of
anti-malarial IgG3. TNF-863A was associated with high
levels of anti-malarial IgG3, whereas TNF1304 was asso-
ciated with variation in the levels of anti-malarial IgG3
and IgG4. It should be stressed that all these polymorph-
isms have been associated with parasitaemia, mild mal-
aria or severe malaria; this suggests that their protective
effect may be partly due to their effect on the IgG sub-
class production.
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